CLICK HERE TO VIEW CURRENT ISSUE

Best of NAMA 2026

Stay Informed
with these

Services
Agri Marketing Update
e-newsletter sent each Monday and Thursday
@AgriMarketing on Twitter
Farm Show Guide
Marketing Services Guide
Books:

National Agri-Marketing Association
NAMA Website
Upcoming Events
Chapters
Agri-Marketing Conf
Best of NAMA 2025










1ST QUARTER: BAYER'S SALES EVEN, NET INCOME DOWN 35%: $1.43 BILLION
Source: Bayer news release

Leverkusen, Germany - The Bayer Group saw a solid start to the year. "Our first quarter puts us in a good spot to deliver in a challenging and important year for the company," CEO Bill Anderson said on Tuesday when presenting the company's Quarterly Statement. He highlighted the substantial growth in earnings in the Pharmaceuticals Division.

"That is an encouraging sign that our operating model is helping teams do more with less," Anderson said. The company expects the division's sales growth and profit margin to come in at the upper end of the range given in the full-year guidance. "We're confident in the momentum of our launches and the fundamentals of our business," he said, commenting on Pharmaceuticals' prospects.

At the same time, Bayer is closely monitoring the current geopolitical and economic uncertainties, and analyzing potential impacts on the company. CFO Wolfgang Nickl said: "Based on the current status of tariffs announcements and our mitigation measures, we expect to manage the impact, and we confirm our outlook at constant currencies for the full year 2025."

Five-year plan for Crop Science to strengthen the company

Bayer has a plan in place to advance its strategic priorities, said Anderson, who had provided a detailed update on the progress being made at the Annual Stockholders' Meeting in late April. Profitability at Crop Science was added as a focus area at the start of the year.

On Tuesday, Bayer confirmed the mid-term ambition for Crop Science. The division is expected to achieve above-market growth and deliver more than 3.5 billion euros of incremental sales from innovation by 2029. By the same year, the division is targeting an EBITDA margin before special items in the mid-20s percentage range. Cash productivity is also set to increase, with Crop Science targeting a free operating cash flow of over 3 billion euros in 2029.

The division has a comprehensive strategy in place to achieve these goals, and has already begun executing it. As previously communicated, the company has launched a five-year plan to combat industry-wide cost pressures, especially in the crop protection business. The measures include streamlining the product portfolio, focusing research and development (R&D) on value-generating innovations, and optimizing the production network.

In doing so, the Crop Science Division aims to not only improve its position in the mid-term but also increase resilience and adaptability across the entire organization to manage macroeconomic and geopolitical uncertainties.

With the global population reaching 10 billion in 2050, the future for agriculture lies in innovative solutions that enable farmers to produce more while reducing the environmental impact and restoring soil health. As the innovation leader of the industry, the Crop Science Division is committed to delivering new blockbuster products and providing tools that enable regenerative agricultural systems.

Examples include the Preceon Smart Corn System, Vyconic soybeans, an industry-first trait package with tolerance to five herbicides, as well as the new herbicide icafolin.

"We are radically focusing on improving profitability, delivering top-notch innovation and leveraging new value pools. We are taking decisive action on our challenges, and we are focusing the business to deliver innovations faster than ever before," said Rodrigo Santos, member of the Board of Management of Bayer AG and head of the Crop Science Division, at a webinar for investors.

Crop Science posts moderate decline in sales as expected

Sales in the agricultural business decreased as expected, falling 3.3 percent (Fx & portfolio adj.) to 7.580 billion euros. Business was mainly down due to the vacatur of the label for the company's dicamba-based crop protection products in the United States, which weighed on seeds and traits, as well as to the expiration of the Movento registration in Europe, which resulted in sales declines at Insecticides. As previously communicated, seeds and traits were additionally impacted by planned volume phasing into the second quarter in North America following a strategic change of distribution network.

In the Herbicides business, sales of glyphosate-based products fell substantially, largely due to volume phasing into subsequent quarters in Latin America and North America, whereas non-glyphosate-based products saw higher volumes against a soft prior-year quarter.

Sales at Fungicides were roughly level with the prior-year quarter, with volume recovery slightly outweighing a decline in prices.

EBITDA before special items at Crop Science decreased by 10.2 percent to 2.557 billion euros, with earnings mainly held back by the decline in sales due to regulatory impacts. The EBITDA margin before special items declined by 2.3 percentage points to 33.7 percent.

To read the entire report click here.


Search News & Articles








Proudly associated with:
Ag Media Council Canadian Agri-food Marketers Alliance National Agri-Marketing Association National Association of Farm Broadcasters
Agricultural Relations Council Agricultural Communicators Network Livestock Publications Council
All content © 2026, Henderson Communications LLC. | User Agreement